NEW YORK, June 21 (Reuters) - Advanced Life Sciences Holdings Inc.'s experimental once-daily antibiotic met its primary goal in a late-stage trial as a pneumonia treatment, the company said on ...
Gator will integrate one of Monod's AI-designed NovoBody™ binding proteins into its industry-leading biolayer interferometry platform NovoBody™ binding proteins deliver superior performance, stability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback